CATALYST PHARMACEUTICALS, INC.
corporate_fare Company Profile
CATALYST PHARMACEUTICALS, INC. (NASDAQ:CPRX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for CPRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-16, rated 9/10. Across its 17 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for CPRX spans 8-K, DEFA14A, DEFM14A, PREM14A.
Recent high-impact activity:
- Angelini Pharma Completes $4.1B Catalyst Takeover, Shares Delisted
- Catalyst Pharma Shareholders Approve $4.1 Billion Acquisition by Angelini Pharma
- Catalyst Pharma Discloses Shareholder Lawsuit Challenging Angelini Merger
- Vamorolone Phase 1 Study Shows Differentiated Profile, Reinforcing Acquisition Value
- Catalyst Pharma Merger Clears HSR Hurdle, Q3 Close Targeted
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$588.99M
Net Income
$214.33M
Diluted EPS
$1.68
Op. Cash Flow
$208.67M
Free Cash Flow
$208.61M
Gross Profit
$501.74M
Operating Income
$257.78M
Cash & Equivalents
$709.17M
Debt / Equity
0.00×
Net Margin
36.4%
Shares Outstanding
122.51M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197490
feed CPRX - Latest Insights
CPRX
Jul 16, 2026, 5:03 AM EDT
CPRX
Jul 08, 2026, 5:29 PM EDT
CPRX
Jun 30, 2026, 5:22 PM EDT
CPRX
Jun 30, 2026, 4:57 PM EDT
CPRX
Jun 23, 2026, 5:23 PM EDT
CPRX
Jun 23, 2026, 5:15 PM EDT
CPRX
Jun 08, 2026, 4:08 PM EDT
CPRX
May 28, 2026, 4:56 PM EDT
CPRX
May 12, 2026, 9:05 AM EDT
CPRX
May 07, 2026, 9:00 AM EDT
CPRX
May 07, 2026, 8:45 AM EDT
CPRX
May 07, 2026, 2:20 AM EDT
CPRX
Apr 27, 2026, 12:30 PM EDT
CPRX
Mar 18, 2026, 5:14 PM EDT
CPRX
Feb 25, 2026, 4:23 PM EST
CPRX
Feb 25, 2026, 4:06 PM EST